Pfizer and BioNTech file BLA for Omicron-targeting Covid-19 vaccine

Pfizer and BioNTech are seeking full approval for their Omicron-targeted bivalent Covid shot, and they’re following an FDA advisory committee’s advice on “harmonizing” vaccine compositions.